MA46461A - Sulfones tricycliques en tant que modulateurs de ror gamma - Google Patents

Sulfones tricycliques en tant que modulateurs de ror gamma

Info

Publication number
MA46461A
MA46461A MA046461A MA46461A MA46461A MA 46461 A MA46461 A MA 46461A MA 046461 A MA046461 A MA 046461A MA 46461 A MA46461 A MA 46461A MA 46461 A MA46461 A MA 46461A
Authority
MA
Morocco
Prior art keywords
sulphones
mmr
tricyclic
gamma modulators
modulators
Prior art date
Application number
MA046461A
Other languages
English (en)
Inventor
Douglas G Batt
T G Murali Dhar
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MA46461A publication Critical patent/MA46461A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
MA046461A 2016-10-10 2017-10-09 Sulfones tricycliques en tant que modulateurs de ror gamma MA46461A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662406085P 2016-10-10 2016-10-10

Publications (1)

Publication Number Publication Date
MA46461A true MA46461A (fr) 2021-04-07

Family

ID=60153546

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046461A MA46461A (fr) 2016-10-10 2017-10-09 Sulfones tricycliques en tant que modulateurs de ror gamma

Country Status (7)

Country Link
US (1) US10968177B2 (fr)
EP (1) EP3523279A1 (fr)
JP (1) JP2019529522A (fr)
KR (1) KR20190057388A (fr)
CN (1) CN110072848A (fr)
MA (1) MA46461A (fr)
WO (1) WO2018071314A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018071620A1 (fr) * 2016-10-13 2018-04-19 Bristol-Myers Squibb Company Sulfones hétérocycliques comme modulateurs de ror gamma
CN113874080B (zh) 2019-02-06 2024-09-27 戴斯阿尔法公司 Il-17a调节剂及其用途
JP7566889B2 (ja) * 2019-09-16 2024-10-15 ダイス・アルファ・インコーポレイテッド Il-17aモジュレーターおよびその使用
CN111004198B (zh) * 2019-12-24 2023-03-28 瑞安宝源化工有限公司 一种苯并吡喃衍生物的合成方法
US12570609B2 (en) 2020-01-24 2026-03-10 Bristol-Myers Squibb Company Tricyclic sulfones as ROR gamma modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
ES2431524T3 (es) 2004-04-13 2013-11-26 Incyte Corporation Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
AR059075A1 (es) * 2006-01-20 2008-03-12 Schering Corp Bencesulfonil - cromano , tiocromano tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
WO2013134660A1 (fr) 2012-03-09 2013-09-12 Fibrogen, Inc. Composés 4-hydroxy-isoquinoléine comme inhibiteurs d'hydroxylase hif
EP2669286A1 (fr) 2012-05-31 2013-12-04 Ares Trading S.A. Dérivés de spiro tétrahydro-benzothiophène utiles pour le traitement de maladies neuro-dégénératives
EP2964644B1 (fr) 2013-03-08 2018-12-26 Amgen, Inc. Composés perfluorés à base de 1,3-oxazin-2-amine condensée avec un cyclopropyle en tant qu'inhibiteurs de la bêta-secrétase et leurs procédés d'utilisation
ES2669208T3 (es) 2014-01-06 2018-05-24 Bristol-Myers Squibb Company Derivados de pirrolidinilsulfona y su uso como moduladores de ROR gamma
TW201600522A (zh) 2014-02-20 2016-01-01 赫孚孟拉羅股份公司 螺-唑酮
CN107709295B (zh) * 2015-05-07 2021-05-04 百时美施贵宝公司 作为RORγ调节剂的三环砜类

Also Published As

Publication number Publication date
EP3523279A1 (fr) 2019-08-14
WO2018071314A1 (fr) 2018-04-19
US10968177B2 (en) 2021-04-06
KR20190057388A (ko) 2019-05-28
US20190233374A1 (en) 2019-08-01
CN110072848A (zh) 2019-07-30
JP2019529522A (ja) 2019-10-17

Similar Documents

Publication Publication Date Title
FR25C1013I1 (fr) Macrocycles de diaryle en tant que modulateurs de protéines kinases
IL283582A (en) Modulators of ror-gamma
IL271455B (en) Mixer with safety mechanisms
EP3347372A4 (fr) Macrocycles peptidomimétiques en tant que modulateurs de mcl-1
EP3517576A4 (fr) Composition de caoutchouc de silicone liquide transparente
MA42049A (fr) Sulfones tricycliques utiles commes modulateurs ror-gamma
MA46373A (fr) Composés utilisés comme modulateurs de ror gamma
HUE054009T4 (hu) Szubsztituált tetrahidrokinolinon vegyületek ROR gamma modulátorként
ES2821790T8 (es) Moduladores de la vía de estrés integrada
BR112017021707A2 (pt) recipientes flexíveis com vedações de reforço
EP3356356A4 (fr) Composés utiles en tant que modulateurs de trpm8
MA55328A (fr) Modulateurs de ror-gamma
EP3459996A4 (fr) Composition de caoutchouc
MA43512A (fr) Composés hétérocycliques utiles en tant que modulateurs du tnf alpha
EP3665416C0 (fr) Lampe de sécurité
MA44772A (fr) 6-aminopyridine-3-yl thiazoles utilisés en tant que modulateurs de ror t
EP3829659A4 (fr) Compositions rafraîchissantes comprenant des modulateurs à libération contrôlée
HUE048902T2 (hu) Új ROR gamma modulátor vegyületek
DK3558278T3 (da) Flydende cannabinoidsammensætning
EP3477362A4 (fr) Modulateur électro-optique
IL251851A0 (en) Thiazoles as modulators of ror gamma t
EP3444298A4 (fr) Composition de caoutchouc
EP3437985A4 (fr) Unité de propulsion de navire
EP3405542A4 (fr) Compositions adhésives optiquement transparentes à double durcissement
EP3450491A4 (fr) Composition de caoutchouc